Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10166255 Intracellular genomic transplant and methods of therapy

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

January 1, 2019

Patent Application Number

15224151

Date Filed

July 29, 2016

Patent Citations Received

US Patent 11883432 Chimeric antigen receptor system with adaptable receptor specificity

0

US Patent 11473060 Compositions and methods for differentiating stem cells into NK cells

US Patent 11471491 Materials and methods for engineering cells and uses thereof in immuno-oncology

US Patent 11497773 Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence

US Patent 11857574 Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

0

US Patent 11873511 Targeted gene insertion for improved immune cells therapy

0

US Patent 11459372 Gene-edited natural killer cells

US Patent 10704021 Acoustic perfusion devices

...

Patent Primary Examiner

Patent abstract

Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10166255 Intracellular genomic transplant and methods of therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool